Return to site

Slide Stainer Market to Reflect Impressive Growth in Healthcare Industry

Predicted to grow at a CAGR of 11.0% during the forecast period, the global Slide Stainer market is estimated to reach USD 4.70 billion by the end of 2023.

Factors contributing to the growth of this market include the increasing incidence of chronic diseases, increasing automation in laboratories, rising geriatric population, and increasing healthcare expenditure.

What the Market Looks Like?
Predicted to grow at a CAGR of 11.0% during the forecast period, the global Slide Stainer market is estimated to reach USD 4.70 billion by the end of 2023.

“By product, the reagents segment accounted for the largest share of the slide stainers market in 2017”
On the basis of product, the reagents segment accounted for the largest share of the global slide stainers market in 2017. The large share of this segment is attributed to the rising prevalence of chronic and infectious diseases, increasing healthcare expenditure, increasing public awareness, and growing demand for automation in diagnostics and clinical research.

“By technology, the hematoxylin & eosin (H&E) segment held the largest share in 2017”
Based on technology, the slide stainers market is segmented into hematoxylin and eosin (H&E), immunohistochemistry, in situ hybridization, cytology, microbiology, hematology, and special stains. In 2017, the H&E segment accounted for the largest share of the slide stainers market.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134046412

Geographical growth scenario of Slide Stainer Market

North America accounted for the largest share of the slide stainers market in 2017, followed by Europe and Asia Pacific. The highly developed healthcare system in this region, the easy accessibility to technologically advanced instruments, and the presence of major key players in the region are the major factors responsible for the large share of the North American slide stainers market.

Leading market players
The prominent players in the Slide Stainer market include Roche (Switzerland), Agilent (US), Danaher (US), BioGenex (US), Thermo Fisher Scientific (US), Sakura (Japan), Biocare Medical (US), Merck Group (Germany), General Data Company (US), and Hardy Diagnostics (US).

Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=134046412

Factors contributing to the growth of this market include the increasing incidence of chronic diseases, increasing automation in laboratories, rising geriatric population, and increasing healthcare expenditure.

What the Market Looks Like?
Predicted to grow at a CAGR of 11.0% during the forecast period, the global Slide Stainer market is estimated to reach USD 4.70 billion by the end of 2023.
“By product, the reagents segment accounted for the largest share of the slide stainers market in 2017”
On the basis of product, the reagents segment accounted for the largest share of the global slide stainers market in 2017. The large share of this segment is attributed to the rising prevalence of chronic and infectious diseases, increasing healthcare expenditure, increasing public awareness, and growing demand for automation in diagnostics and clinical research.
“By technology, the hematoxylin & eosin (H&E) segment held the largest share in 2017”
Based on technology, the slide stainers market is segmented into hematoxylin and eosin (H&E), immunohistochemistry, in situ hybridization, cytology, microbiology, hematology, and special stains. In 2017, the H&E segment accounted for the largest share of the slide stainers market.
Geographical growth scenario of Slide Stainer Market
North America accounted for the largest share of the slide stainers market in 2017, followed by Europe and Asia Pacific. The highly developed healthcare system in this region, the easy accessibility to technologically advanced instruments, and the presence of major key players in the region are the major factors responsible for the large share of the North American slide stainers market.
All Posts
×

Almost done…

We just sent you an email. Please click the link in the email to confirm your subscription!

OKSubscriptions powered by Strikingly